AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
155 hedge funds and large institutions have $712M invested in Aerie Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
–
Holders Change %
0%
% of All Funds
3.19%
Holding in Top 10
1
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-83.33%
% of All Funds
0.02%
New
27
Increased
55
Reduced
54
Closed
27
Calls
$572K
Puts
$1.3M
Net Calls
-$723K
Net Calls Change
+$3.83M
Top Buyers
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$20.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$19.8M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.4M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11M |
| 5 |
Morgan Stanley
New York
|
+$7.54M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$83M |
| 2 |
DM
Deerfield Management
New York
|
-$30.1M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.69M |
| 4 |
First Manhattan
New York
|
-$7.79M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.85M |
